Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: High-risk plaques (HRP) in non-flow-limiting, deferred non-culprit lesions have been associated with adverse short-term cardiovascular outcomes after myocardial infarction (MI). However, the long-term prognostic implications remain largely unknown. AIMS: This study sought to evaluate the long-term association between HRP and clinical outcome after MI Methods: In the prospective, observational PECTUS-obs study, 438 patients with recent MI underwent optical coherence tomography (OCT) of all fractional flow reserve-negative non-culprit lesions. Patients were grouped according to the presence or absence of at least one OCT-identified HRP. The current study evaluates the final long-term outcome. The primary patient-level endpoint was defined as major adverse cardiovascular events (MACE), a composite of cardiac death, non-fatal MI, or unplanned revascularisation, excluding all periprocedural, indeterminate, and stent failure-related events. RESULTS: After a median follow-up of 1,828 days (interquartile range [IQR] 1,821-1,842), the presence of at least one HRP was associated with MACE (hazard ratio [HR] 1.87, 95% confidence interval [CI]: 1.11-3.14; p=0.017). Among the individual endpoint components, non-fatal MI (HR 4.07, 95% CI: 1.23-13.52; p=0.013) and unplanned revascularisation (HR 1.97, 95% CI: 1.07-3.64; p=0.027) occurred more frequently in patients with at least one HRP. In an exploratory landmark analysis, the risk associated with presence of HRP was observed only during the first 2 years of follow-up. The lesion-level incidence of target lesion failure did not differ significantly between groups (HR 1.65, 95% CI: 0.91-2.96; p=0.097). CONCLUSIONS: Non-flow-limiting, high-risk non-culprit plaques are associated with adverse patient-level clinical outcomes during long-term follow-up after MI, potentially with a more pronounced short-term risk. CLINICALTRIALS: gov: NCT03857971.
Source: EuroIntervention
Authors: Rick H.J.A. Volleberg, Jan-Quinten Mol, Geert A.A. Versteeg, Joske L. van der Zande, Anouar Belkacemi, Renicus S. Hermanides, Martijn Meuwissen, Alexey V. Protopopov, Peep Laanmets, Oleg V. Krestyaninov, Casper F. Laclé, Rohit M. Oemrawsingh, Jan-Peter van Kuijk, Karin Arkenbout, Dirk J. van der Heijden, Saman Rasoul, Erik Lipšic, Laura Rodwell, Cyril Camaro, Peter Damman, Tomasz Roleder, Elvin Kedhi, Maarten A.H. van Leeuwen, Robert-Jan M. van Geuns, Niels van Royen
Institutions: Radboud University Medical Center, Isala, Amphia Ziekenhuis, Krasnoyarsk State Medical University, Krasnoyarsk Regional Clinical Hospital, North Estonia Medical Centre, Meshalkin National Medical Research Center, Albert Schweitzer Ziekenhuis, St. Antonius Ziekenhuis, Canisius-Wilhelmina Ziekenhuis, Tergooi, Medisch Centrum Haaglanden, Stichting Haaglanden Medisch Centrum, Maastricht University Medical Centre, Zuyderland Medisch Centrum, University Medical Center Groningen, Wrocław University of Science and Technology, McGill University Health Centre, Royal Victoria Hospital, McGill University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7162502218
